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Introduction
Left ventricular (LV) systolic dysfunction due to ischemic
cardiomyopathy (I-CMP) leads to reduced exercise capac-
ity. Ventricular-vascular coupling (VVC), a ratio of effec-
tive arterial to LV elastance, represents forward flow
efficiency of LV, independent of mitral regurgitation.
Purpose
In I-CMP patients, we sought to a) assess relationship
between resting VVC and maximum oxygen consumption
corrected for peak heart rate (MVO2/pHR), an accurate
measure of exercise capacity in patients on β-blockers, and
b) compare value of VVC versus other determinants of
exercise capacity.
Methods
43 patients with I-CMP (age 59 ± 9 years, 88% on β-
blocker) underwent cardiopulmonary exercise testing,
echocardiography and cardiac magnetic resonance (CMR,
1.5 T Siemens Scanners, Erlangen Germany) for cardiac
transplant evaluation. MVO2/pHR and diastolic filling
variables (echocardiography) were measured in a stand-
ard fashion. CMR LV indices [end-systolic (ESV), end-
diastolic (EDV), stroke volume (SV), all in ml, and LVEF]
were measured using the standard contiguous short-axis
slices from apex to base, using the balanced steady state
free precession cine sequence (TE = 1.6 msec, TR = 3.3
msec, flip angle = 70° and slice thickness 8–10 mm, field
of view varied from 228–330 in the x-direction and 260–
330 in the y-direction and matrix size varied from 140–
180 in the x-direction and 256 in the y-direction, giving a
spatial resolution of 1.5–2.1 mm (x-direction) by 1.1–1.4
mm (y-direction). For patients able to suspend respira-
tion, breath hold duration was 10–15 sec, depending on
the heart rate; otherwise, images were acquired using 3
signal averages. Subsequently, off-line analysis was per-
formed using Argus analytical software (Siemens Medical
Solutions, Erlangen, Germany) to assess LV volumes and
LVEF, in a standard fashion. VVC was calculated as: [Effec-
tive arterial elastance (end systolic pressure ÷ stroke vol-
ume index)/LV end-systolic elastance (end systolic
pressure ÷ LV systolic volume index)].
Results
Mean LVEF, ESV, EDV, and SV were 24 ± 8%, 228 ± 107
ml, 297 ± 111 ml, and 66 ± 20 ml respectively. Mean
MVO2/pHR was 13 ± 3 ml/beat. Predictors of MVO2 are
shown in Table 1. On stepwise regression, only VVC sig-
nificantly predicted MVO2/pHR.
Conclusion
In I-CMP patients with LV dysfunction, VVC predicts
MVO2/pHR that can potentially be used as a potential
therapeutic target.
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Table 1: Univariate and multivariate predictors pf MVO2/peak HR.
MVO2/peak HR




NYHA class -0.14 0.4
Baseline SBP 0.22 0.16
Baseline DBP -0.02 0.9
Echocardiographic and CMR features
E max -0.39 0.009 0.1
E/A ratio -0.23 0.1
E wave deceleration time 0.35 0.02 0.5
CMR features
LV end-systolic volume -0.41 0.006 0.9
LV end-diastolic volume -0.28 0.07
Stroke volume 0.14 0.3
LV ejection fraction 0.36 0.02 0.6
Ventricular vascular coupling 0.45 0.002 0.001
Ea -0.28 0.09
Ees 0.39 0.009
NYHA indicates New York Heart Association; SBP, systolic blood pressure; DBP, diastolic blood pressure; E max, mitral E wave velocity; LV, left 
ventricle; Ea, Arterial elastance; Ees, left ventricular systolic elastance.Page 2 of 2
(page number not for citation purposes)
